Emmanuelle Quiles

Drove strategic oversight of $6B therapeutic portfolio, aligning clinical and commercial strategy with a focus on the US market - Partnered cross-functionally with R&D to prioritize market shaping and lifecycle strategy - Led campus relocation effort (500+ employees), enhancing engagement and external visibility - Executive sponsor for women's leadership in EMEA.

Directed affiliate transformation into French market leader (>$1 B turnover) - Launched multiple therapies, delivering 30% growth in oncology - Founded "AI for Health" with Artefact; France's benchmark event in AI-health convergence - Appointed by French government to lead national AI & Health strategy initiative.

Founded and scaled venture in diabetes care (medical devices, nutraceuticals, cosmetics)

• - Built regulatory, quality and sales infrastructure; secured EU partnerships - Deployed retail distribution model through Italian pharmacies.